Literature DB >> 22776053

Use of ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography in a miniature pig (Sus scrofa domestica) with pneumonia.

Jong-In Kim1, Young Ah Lee, Jae Won Lee, Sang Min Jeong, Hyun Woo Chung, Jin Soo Han.   

Abstract

A 1-y-old male miniature pig housed in our laboratory facility was evaluated for weight loss and rough coat condition. CBC results revealed neutrophilia. Radiography of the thoracic area showed increased opacity throughout the thoracic cavity except for the right caudal lobe. ¹⁸F-labeled fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET-CT) revealed elevated standard uptake values in the area corresponding to the radiologic findings. Follow-up thoracic radiography taken 2 wk after FDG-PET-CT showed several interval changes, including markedly decreased opacity throughout the entire thoracic cavity. Necropsy revealed adhesions between the upper portion of the caudal lobe of the left lung and thoracic wall. ELISA for several closely related infectious species confirmed the presence of antibody to Actinobacillus pleuropneumoniae serovar V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22776053      PMCID: PMC3364705     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  32 in total

Review 1.  Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection.

Authors:  Janine T Bossé; Håkan Janson; Brian J Sheehan; Amanda J Beddek; Andrew N Rycroft; J Simon Kroll; Paul R Langford
Journal:  Microbes Infect       Date:  2002-02       Impact factor: 2.700

Review 2.  Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP.

Authors:  E Galea; D L Feinstein
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

3.  Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease.

Authors:  P D Shreve
Journal:  Eur J Nucl Med       Date:  1998-03

4.  Evidence of nitric oxide synthase 2 activity in swine naturally infected with Actinobacillus pleuropneumoniae.

Authors:  W-S Cho; C Chae
Journal:  Vet Pathol       Date:  2003-05       Impact factor: 2.221

Review 5.  Applications of PET in lung cancer.

Authors:  A Al-Sugair; R E Coleman
Journal:  Semin Nucl Med       Date:  1998-10       Impact factor: 4.446

6.  Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography.

Authors:  Delphine L Chen; Thomas W Ferkol; Mark A Mintun; Jessica E Pittman; Daniel B Rosenbluth; Daniel P Schuster
Journal:  Am J Respir Crit Care Med       Date:  2006-03-16       Impact factor: 21.405

7.  Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.

Authors:  Daisuke Uesaka; Yoshiki Demura; Takeshi Ishizaki; Shingo Ameshima; Isamu Miyamori; Masato Sasaki; Yasuhisa Fujibayashi; Hidehiko Okazawa
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

8.  Hematologic values of the yucatan miniature pig.

Authors:  A H Parsons; R E Wells
Journal:  Vet Clin Pathol       Date:  1998       Impact factor: 1.180

9.  Evaluation of a Killed Vaccine Against Porcine Pleuropneumonia Due to Haemophilus pleuropneumoniae.

Authors:  R Higgins; S Larivière; K R Mittal; G P Martineau; P Rousseau; J Cameron
Journal:  Can Vet J       Date:  1985-02       Impact factor: 1.008

10.  Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation.

Authors:  Niklas Jasper; Jan Däbritz; Michael Frosch; Markus Loeffler; Matthias Weckesser; Dirk Foell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

View more
  1 in total

1.  Use of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography to aid in diagnosing intestinal adenocarcinoma in 2 rhesus macaques (Macaca mulatta).

Authors:  Debra J Caporizzo; Anna E Kwiatkowski; Ming-Kai Chen; Amanda P Beck; Carmen J Booth; Caroline Zeiss; Peter C Smith; Jodi A Carlson Scholz; Steven R Wilson
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.